Category: French

Fresh from a European cancer conference that was all about antibody-drug conjugates, GSK has turned to French biotech Syndivia for a preclinical prostate cancer prospect. Syndivia’s ADC has already proven…

French antibody specialist Adcytherix has added a 105 million euro ($122 million) series A to its coffers, money the Marseille-based biotech will use to push its lead antibody drug conjugate…